| T-cell receptor repertoire sequencing and its applications: focus on infectious diseases and cancer L Mazzotti, A Gaimari, S Bravaccini, R Maltoni, C Cerchione, M Juan, ... International journal of molecular sciences 23 (15), 8590, 2022 | 20 | 2022 |
| Chimeric antigen receptor T-cell therapy: what we expect soon M Martino, V Naso, B Loteta, FA Canale, M Pugliese, C Alati, G Musuraca, ... International Journal of Molecular Sciences 23 (21), 13332, 2022 | 11 | 2022 |
| Amyotrophic lateral sclerosis as an adverse drug reaction: a disproportionality analysis of the food and drug administration adverse event reporting system A Gaimari, M Fusaroli, E Raschi, E Baldin, L Vignatelli, F Nonino, ... Drug Safety 45 (6), 663-673, 2022 | 9 | 2022 |
| Tamoxifen protects breast cancer patients from COVID-19: first evidence from real world data S Bravaccini, F Nicolini, W Balzi, I Azzali, A Calistri, C Parolin, A Vitiello, ... | 3 | 2021 |
| Why the complications of COVID-19 patients differ in elderly and young cancer patients S Bravaccini, F Nicolini, M Zanoni, A Gaimari, C Cerchione, R Maltoni, ... Translational Oncology 26, 101541, 2022 | 1 | 2022 |